Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Yu E, Rumble R, Agarwal N, Cheng H, Eggener S, Bitting R, Beltran H, Giri V, Spratt D, Mahal B, Lu K, Crispino T, Trabulsi E. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. Journal Of Clinical Oncology 2025, 43: 748-758. PMID: 39787437, DOI: 10.1200/jco-24-02608.Peer-Reviewed Original ResearchMeSH KeywordsGenetic TestingGenomicsGerm-Line MutationHumansMaleNeoplasm MetastasisProstatic NeoplasmsConceptsMetastatic prostate cancerSomatic genomic testingProstate cancerMetastatic castration-resistant prostate cancerClinical trialsCastration-resistant prostate cancerGenomic testingPoly(ADP-ribose) polymerase inhibitorsSystematic reviewMetastatic biopsiesSurvival benefitASCO guidelinesPrognostic informationClinical statusGermline testingPolymerase inhibitorsPatientsScreening implicationsPubMed databaseCancerMultidisciplinary panelEligibility criteriaGermlineLiterature searchSequencing findings
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply